Univest
Univest
  • Markets

Indraprastha Medical Corporation (INDRAMEDCO) 52 Week Low Streak Continues For Second Straight Session

  • October 1, 2026
  • Posted by: Chaitanya Auti
  • Category: News
No Comments
Indraprastha Medical Corporation 52 Week Low Streak
Indraprastha Medical Corporation Ltd. (INDRAMEDCO) share price is trading within 2% of its 52-week low today and stood at Rs 318.1, down 1.01% from the previous close. Market cap was Rs 2,945.91 crore.

Indraprastha Medical Corporation 52 Week Low Streak has now run into a second straight session, with the stock trading within 2% of its 52-week low and moving down 3.06% across the streak. The latest trade showed a low of Rs 317 and a last price of Rs 318.1, keeping the stock close to its one-year trough. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued move.

At 9:23 AM IST, the stock was trading below the previous close of Rs 321.35 after opening at Rs 321.1 and touching the same level as the day’s high. With a market capitalisation of Rs 2,945.91 crore, the repeated near-low trade matters more than a single weak print because it shows the weakness has persisted across sessions rather than appearing only once. That is the key lens for this Indraprastha Medical Corporation 52 Week Low Streak article.

Table of Contents

Toggle
  • Indraprastha Medical Corporation 52 Week Low Streak: Consecutive Low Analysis
  • What The Repeated 52-Week Lows Show
  • Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching
  • About The Company
  • Frequently Asked Questions
    • What does the Indraprastha Medical Corporation 52 Week Low Streak mean?
    • How many sessions has the stock stayed near its 52-week low?
    • Did the stock make a new 52-week low today?
    • How does the valuation compare with healthcare peers?
    • What do the profitability ratios show?
    • What should investors monitor next?
  • Track Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Share Price on Univest

Indraprastha Medical Corporation 52 Week Low Streak: Consecutive Low Analysis

Metric Value
Current Price Rs 318.1
Previous Close Rs 321.35
Today's Move Rs -3.25 (-1.01%)
Open Rs 321.1
High Rs 321.1
Low Rs 317
Market Capitalisation Rs 2,945.91 crore

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) traded at Rs 318.1 versus the previous close of Rs 321.35, a fall of 1.01%. The stock opened at Rs 321.1, reached a high of Rs 321.1, touched a low of Rs 317.

Indraprastha Medical Corporation share price today was under pressure again as the stock traded at Rs 318.1, down Rs 3.25 or 1.01% from the previous close of Rs 321.35. The day opened at Rs 321.1 and touched a high of Rs 321.1, which means the opening print also marked the intraday top so far. The low of Rs 317 placed the stock very close to its one-year trough, keeping the Indraprastha Medical Corporation 52 Week Low Streak intact.

The price has been moving in a tight band around the lower end of its recent range, and that narrow structure is part of why the repeated weak trade is important. A single-session drop can be noisy, but this stock has stayed near its 52-week low for two consecutive sessions. The cumulative move across the streak is down 3.06%, which is sharper than the intraday loss alone suggests. For readers tracking Indraprastha Medical Corporation Stock News, the point is not just the day’s decline, but the fact that the stock is still lingering near the lower boundary of its yearly range.

Market capitalisation stood at Rs 2,945.91 crore, which keeps the company in the mid-range of healthcare names by value. The current price is only slightly above the day low, so the market is still testing the same weak zone rather than moving away from it. In that context, Indraprastha Medical Corporation Share Price Today is best read as a continuation of the broader 52 Week Low Streak rather than as a one-off move.

What The Repeated 52-Week Lows Show

The Indraprastha Medical Corporation 52 Week Low Streak suggests that the stock is being priced close to its yearly floor for more than one session, which is more meaningful than an isolated dip. The most recent Univest record shows a repeated near-low pattern across two sessions, with the cumulative decline across the streak at 3.06%. That tells investors the weakness has persisted long enough to merit closer tracking in any stock performance review.

This does not by itself explain why the stock is under pressure. The latest market data confirms the pattern of repeated near-yearly lows, but it does not identify a company-specific trigger. For readers searching for Indraprastha Medical Corporation Stock Analysis or asking why the stock keeps trading near its 52-week trough, the correct answer is that the chart is showing persistence, not a proven cause. The move is still a decline story, and the present focus is on whether the price stabilises away from the yearly floor or remains pinned near it.

When a stock stays near the lower end of its one-year range for consecutive sessions, the market is signalling caution through price behaviour alone. In this case, the repeated trade near the yearly low matters more than the day’s point change. It keeps the stock inside the group of stocks at one year low today that readers often monitor for further downside risk.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Fundamental Analysis

Metric Value
Market Capitalisation Rs 2,945.91 crore
P/E Ratio 15.67x
P/B Ratio 3.7x
ROE 27.47%
ROCE 37.7%
EPS Rs 20.51
Book Value Per Share Rs 86.85
Dividend Yield 1.24%

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) fundamental metrics show P/E 15.67x, P/B 3.7x, ROE 27.47%, ROCE 37.7%. These figures provide context only and are not a buy or sell signal.

Indraprastha Medical Corporation Ltd. has a market capitalisation of Rs 2,945.91 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 15.67x, P/B at 3.7x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.47% and ROCE of 37.7%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.51, book value per share of Rs 86.85, dividend yield of 1.24%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 39.27x, median ROE of 12.82%, median ROCE of 15.7%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 15.67x
Benchmark Median P/E 39.27x
Benchmark Average P/E 83.15x
Benchmark P/E Range 0x to 1,517.44x
Company P/B Ratio 3.7x
Benchmark Median P/B 3.59x
Company ROE 27.47%
Benchmark Median ROE 12.82%
Company ROCE 37.7%
Benchmark Median ROCE 15.7%
Company Market Capitalisation Rs 2,945.91 crore
Benchmark Median Market Cap Rs 496.71 crore

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 15.67x, which is below the benchmark median of 39.27x, a difference of -60.1%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROE of 27.47%, which is above the benchmark median of 12.82%, a difference of +114.27%. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROCE of 37.7%, which is above the benchmark median of 15.7%, a difference of +140.13%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
KMC Speciality Hospitals (India) Ltd. KMCSHIL 2,568.59 46.05 11.32 24.94 27.25
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,493.91 32.72 6.75 25.22 29.21
Artemis Medicare Services Ltd. ARTEMISMED 4,776.89 42.18 5.34 12.72 15.83
Krsnaa Diagnostics Ltd. KRSNAA 1,706.92 17.84 1.76 10.97 13.08
SURAKSHA DIAGNOSTIC LIMITED SURAKSHA 1,654.35 44.63 6.23 13.81 24.97

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 15.67x compared with the displayed peer median of 42.18x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.47% compares with a peer median of 13.81% across the companies shown in the table. ROCE stood at 37.7% versus the displayed peer median of 24.97%, providing a capital-efficiency comparison. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a market capitalisation of Rs 2,945.91 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.

Why Investors Are Watching

  • The stock has now traded within 2% of its 52-week low for a second straight session, making the Indraprastha Medical Corporation 52 Week Low Streak the main short-term market signal.
  • The cumulative move across the streak is down 3.06%, which is more useful to track than only the latest intraday change.
  • The price is still hovering near the lower end of its yearly range, so readers watching 52 Week Low Stocks are likely to keep it on their list.
  • Fundamental ratios show a lower P/E than many healthcare peers, while ROE and ROCE remain stronger than the latest Univest industry medians.
  • The latest data confirms the repeated-low pattern, but it does not establish a company-specific reason for the continued weakness.

About The Company

Indraprastha Medical Corporation Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. Its listed market value stands at Rs 2,945.91 crore in the supplied snapshot, and its price behaviour is now being watched through the lens of the Indraprastha Medical Corporation 52 Week Low Streak. The company’s profitability ratios remain part of the conversation because they help frame the valuation backdrop.

The stock’s latest market profile places it among healthcare names that are often compared on earnings, book value, and operating returns. For readers tracking Indraprastha Medical Corporation Share Price Update or searching for Indraprastha Medical Corporation Stock News, the important point is that the company is now in a repeated near-yearly-low phase rather than a single-day dip. That makes the pattern relevant to both short-term traders and longer-horizon market watchers.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.

Frequently Asked Questions

What does the Indraprastha Medical Corporation 52 Week Low Streak mean?

Ans. It means the stock has traded within 2% of its 52-week low for consecutive sessions. In this case, the streak has reached a second straight session, showing repeated weakness near the yearly trough.

How many sessions has the stock stayed near its 52-week low?

Ans. The stock has stayed within 2% of its 52-week low for two consecutive sessions. The latest Univest data marks that as a second straight session near the yearly low. The stock moved -1.01% during the session.

Did the stock make a new 52-week low today?

Ans. The data shows the stock traded near its 52-week low again, but it does not say that a new 52-week low was set. The correct reading is repeated near-low trading.

How does the valuation compare with healthcare peers?

Ans. The stock’s P/E of 15.67 is below the industry median in the latest Univest peer set, while its P/B of 3.7 is close to the median. That creates a mixed valuation picture relative to peers.

What do the profitability ratios show?

Ans. ROE is 27.47% and ROCE is 37.7%, both above the latest Univest industry medians. EPS stands at Rs 20.51, and book value is Rs 86.85, which helps frame the company’s fundamental profile.

What should investors monitor next?

Ans. Investors should watch whether the stock continues to trade near its yearly low or starts moving away from that zone. They may also track valuation, profitability, and broader sector behaviour alongside the price pattern.

Track Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Share Price on Univest

Use Indraprastha Medical Corporation Ltd. (INDRAMEDCO) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.



Leave a Reply Cancel reply